Global Clinical Laboratory Services Industry

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Global Clinical Laboratory Services Industry

http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_clinical_laboratory_services_industry.html

This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles164 companies including many key and niche players such as -

ADICON Clinical Laboratories, Inc.
ARUP Laboratories
Asuragen, Inc.
Atherotech Diagnostics Lab
Bio-Reference Laboratories, Inc.
Clarient, Inc.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Hospital-Based Medical Laboratories I-3
Others I-4
Physician's Office-Based Medical Labs I-4
Independent Laboratories I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Prelude II-1
Despite Challenges, Emerging Markets Provide Growth Opportunities II-2
Developed Nations: Cost Pressures Necessitate New Strategies II-3
Economic Uncertainty Affects Spending on Healthcare Services II-3
Major Growth Drivers: A Review II-3
Rising Healthcare Needs of Aging Global Population II-4
Table 1: Over-65 Years Population as a % of Total Population
(2010 & 2020P) (includes corresponding Graph/Chart) II-5

Table 2: Elderly Population (65+ Years) as a % of Total
Population (2000 & 2025) (includes corresponding
Graph/Chart) II-5

Table 3: Global Population Statistics for the 65+ Age Group
(2012) (includes corresponding Graph/Chart) II-6

Table 4: Life Expectancy Rates at Birth by Geographic Region
(1990 & 2011) (includes corresponding Graph/Chart) II-7
Increase in Healthcare Spending in Emerging Markets II-7
Table 5: Healthcare Spending as % of GDP in Select Countries
(2011) (includes corresponding Graph/Chart) II-8
Increasing Awareness Levels II-8
Need to Cut Healthcare Costs II-8
Rising Incidence of Diseases II-8
World Cancer Statistics: Incidence and Mortality Data II-8
Table 6: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America & the Caribbean, and Africa (includes corresponding
Graph/Chart) II-9

Table 7: World Cancer Mortality by Geographic Region and
Gender (2012): Number of Cancer-Related Deaths (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America & the Caribbean, and Africa (includes corresponding
Graph/Chart) II-9

Table 8: New Cancer Cases in the World by Affected Site
(2012) (In Thousands) (includes corresponding Graph/Chart) II-10

Table 9: Global Incidence of Common Cancers in Men (2012):
Number of New Cases Reported in Thousands for Lung &
Bronchus, Prostate, Colorectal and Liver Cancers (includes
corresponding Graph/Chart) II-10

Table 10: Global Incidence of Common Cancers in Women
(2012): Number of New Cases Reported in Thousands for
Breast, Colorectal, Lung & Bronchus and Liver Cancers
(includes corresponding Graph/Chart) II-11

Table 11: Global Cancer Mortality in Men for Select Cancers
(2012): Number of Deaths in Thousands for Lung & Bronchus,
Liver, Colorectal and Prostate Cancers (includes
corresponding Graph/Chart) II-11

Table 12: Global Cancer Mortality in Women for Select
Cancers (2012): Number of Deaths in Thousands for Breast,
Lung & Bronchus, Colorectal and Liver (includes
corresponding Graph/Chart) II-12
Cancer Prone Sites based on Age II-12
Global HIV Statistics II-12
Table 13: Global Summary of the AIDS Epidemic in 2011
(includes corresponding Graph/Chart) II-12
Some Significant HIV Statistics by Region (2011) II-13
Increasing Role of Clinical Labs in Testing of Infectious
Diseases II-13
Table 14: Reported Cases of Major Infectious by Geographic
Region (2011) II-14
Esoteric Testing Market: Faster Growth than Routine Testing
Segment II-15
Increasing Role of Advanced Tests in Clinical Treatment
Decision Making II-15
Opportunities in Personalized Medicine and Clinical Trial
Services II-15
Clinical Labs Opt for Reagent Rental Contracts to Sustain
Operations II-16
Cancer Testing Market: Opportunity for Clinical Labs II-16
Shortened Hospitalization Enhances Significance of Medical Labs II-16
Lab Automation Speeds Up II-17
Heightened Use of IT Systems in Clinical Laboratories II-17
Laboratory Outsourcing Trend Gains Strength II-17
Autoimmune Disease Testing: Labs Seek Cost-Effective & High
Productivity Options II-18
Assessing the Impact of Point-of-Care Testing on Clinical Labs II-18
IVD Market Growth: An Indication of Growth in Clinical Labs
Market II-19
Laboratory Budget Allocations Affected by Prevailing Economic
Environment II-20
POLs: Reducing Turnaround Times for Testing II-20
Challenges Facing Lab Testing Market II-21

2. COMPETITIVE LANDSCAPE II-22
Introduction II-22
Quest Diagnostics & LabCorp: The Leading Independent Labs II-22
Consolidation Activity Continues to Strengthen II-23
Major Clinical Laboratory Transactions (2011-2013) II-23

3. CLINICAL LABORATORY SERVICES - AN INTRODUCTION II-25
Clinical Laboratory Services II-25
What is a Medical Laboratory? II-25
Laboratory Medicine II-25
Anatomic Pathology II-26
Clinical Pathology II-26
Types of Tests Conducted in Medical Labs II-28
Routine Tests II-28
Esoteric Tests II-28
Anatomic Pathology Services II-28
Types of Clinical Laboratories II-29
Hospital-Based Laboratories II-29
Physician's Office-Based Medical Labs II-29
Reference Laboratories II-29
Potential Customers for Medical Laboratories II-30
Work Process in Clinical Labs II-30
Specimen Processing & Result Analysis in Clinical Labs II-30
Laboratory Information Systems II-31
Conducting Lab Tests II-31
Key Personnel in Medical Labs II-31
Role of Medical Technologists II-32
Role of Medical Technicians II-33
Analysis, Validation and Interpretation of Results II-33
Testing Equipment II-33
Bio-Safety Hazards and Equipment Design II-33
Essential Bio-safety Equipment in Clinical Laboratories II-34
Personal Protection Equipment in Medical Labs II-34
Economic Model Followed By Testing Laboratories II-34
Revenues II-35
Expenses II-35
Dichotomy between Customers and Payers in Medical Lab Industry II-35
Impact of Environmental Factors on Lab Tests II-35
Regulatory Overview II-36
Legislative & Regulatory Environment Worldwide II-36
GCLP II-36
ISO 15189:2003 II-37
ISO 15189 Accreditation II-37
ILAC II-37

4. PRODUCT INNOVATIONS/INTRODUCTIONS II-38
Genomic Health Launches Oncotype DX Prostate Cancer Test II-38
Clarient Rolls Out Next-Generation Sequencing Assay II-38
SilverStaff Clinical Laboratories to Provide BGM Galectin-3®
Test of BG Medicine II-38
Quest Diagnostics Unveils Dementia Clinical Diagnostic Panel II-39
Psychemedics Unveils Hair Alcohol Test II-39
Prometheus Laboratories Introduces PROMETHEUS® Anser™ ADA II-40
NeoGenomics Launches Clinical Molecular Tests for MDS II-40
LipoScience Introduces Vantera Clinical Analyzer for
Cardiovascular Disease Management II-40
Atherotech Diagnostics Lab Introduces AspirinWorks® Test II-41
GeneDx to Introduce Comprehensive Genetic Tests Suite for
Ovarian and Breast Cancers II-41
Enzo Clinical Labs Collaborates with Oncimmune to Launch Novel
Diagnostic Test II-41
Myriad RBM Introduces Oncology® v. 2.0 Test II-42
NeoGenomics Introduces NeoSITE™ Barrett's Esophagus FISH Test II-42
diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity II-42

5. RECENT INDUSTRY ACTIVITY II-43
Quest Diagnostics Acquires Dignity Health's Clinical Operations II-43
Quest Diagnostics Takes Over Laboratory Operations of Concentra II-43
LifeLabs Acquires BC Biomedical II-43
JLL Takes Over BioClinica and CoreLab II-44
Quest Diagnostics Takes Over ConVerge Diagnostic Services II-44
Spectra Laboratories Acquires Shiel Medical Laboratory II-44
Gamma-Dynacare Medical Acquires Controlling Stake in Impact
Genetics II-45
Proove Biosciences Takes Over Colwell Clinical Labs II-45
BioReference to Acquire Laboratory Business of Edge BioSystems II-45
Cleveland Clinic Laboratories Signs Agreement with ACL for
Specialized Testing Services II-46
Cancer Genetics and Mayo Clinic Establish JV, Oncospire Genomics II-46
HDL to Form Joint Venture with GeneNews for ColonSentry Test II-46
Gamma-Dynacare Collaborates with OSR Medical II-46
Mayo Medical and Mayo Clinic in Collaboration Agreement with
bioTheranostics II-47
MACL & Oncimmune® Offer EarlyCDT®-Lung Blood Test II-47
Luminex and NMTC Collaborate for Lab-Developed Panel II-47
ARUP Partners with Predictive Biosciences II-47
PrimeraDx and Quest Diagnostics Ink Co-Development Agreement II-48
DaVita Labs Inks Research Collaboration Agreement with Myriad RBM II-48
Rochester General Health System Inks Partnership Agreement
with Mayo Medical Laboratories II-48
Corgenix Medical Inks Agreement with Atherotech Diagnostics Lab II-49
MDxHealth Inks Marketing Partnership with Bostwick Laboratories II-49
ARUP Laboratories Inks Agreement with Oncimmune® II-49
Instituto Hermes Pardini Takes Over Diagnostika - Unidade de
Patologia e Citologia II-50
LifeLabs Medical Laboratory Acquires CML HealthCare II-50
Mayo Medical Conducts NMR Lipoprotein Particle Testing with
LipoScience Vantera® Clinical Analyzer II-50
Bio-Reference Signs Agreement with Natera to Commercialize
Panorama™ NIPT II-51
Myriad Genetics Signs Companion Diagnostic Deal with TESARO II-51
OpGen Establishes CLIA-Certified Clinical Services Laboratory
and Introduces Microbial Genetic Tests for HAIs II-51
Echevarne to Distribute Natera's Panorama™ Prenatal Test
Panorama in Spain II-51
AccelPath Acquires DigiPath II-52
OPKO Health Takes Over Prost-Data II-52
Ampersand Takes Over Willow Laboratories II-52
LabCorp Takes Over MEDTOX II-53
WCP Takes Over Sterling Reference Laboratories II-53
Gamma-Dynacare to Take Over LifeLabs Quebec II-53
Quest Diagnostics Takes Over S.E.D. Medical Laboratories II-54
TrovaGene Acquires MultiGEN Diagnostics Clinical Laboratory
Business II-54
Bode Technology Group Takes Over Chromosomal Laboratories II-54
Becton, Dickinson and Company Takes Over KIESTRA Lab Automation II-54
CD Diagnostics Acquires Stake in CML II-55
Quest Diagnostics to Acquire UMass' Clinical Laboratory
Outreach Business II-55
AmperSand Capital to Acquire Calloway II-55
Genova Diagnostics and Metametrix Merge Operations II-55
Al Borg to Merge Operations with Al Mokhtabar II-56
InCyte Pathology Signs Preliminary Merger Deal with Eastside
Pathology II-56
Gamma-Dynacare Acquires Alcohol and Drug Testing Business of
Maxxam Analytics II-56
ADICON Inks Strategic Collaboration Framework Contract with
Siemens II-57
Myriad RBM Signs Collaboration Agreement with Sanofi and PHRI
for Protein Bio-marker Research II-57
DLMP and MML Collaborate with Kindstar for Esoteric Tests II-58
Qiagen Signs Co-Marketing Pact with KingMed Diagnostics II-58
WuXi PharmaTech Enters into JV Agreement with PRA II-58
AKUH Establishes High-Tech Stat Laboratory in Rawalpindi II-59
Warburg Pincus Collaborates with Lab Industry Veterans to
Launch RDL II-59
Covance and BML Expand CB Trial Lab II-60
Bio-Reference Laboratories to Establish Laboratorio Buena Salud II-60
The University of Western Australia Establishes Translational
Cancer Pathology Laboratory II-60
Khandelwal Laboratories Establishes KLab in Nepal II-60

6. FOCUS ON SELECT PLAYERS II-61
ADICON Clinical Laboratories, Inc. (China) II-61
ARUP Laboratories (US) II-61
Asuragen, Inc. (US) II-61
Atherotech Diagnostics Lab (US) II-62
Bio-Reference Laboratories, Inc. (US) II-62
Bioscientia Institut für Medizinische Diagnostik GmbH (Germany) II-62
Clarient, Inc. (US) II-62
DaVita, Inc. (US) II-63
Enzo Clinical Labs (US) II-63
Gaoxin - Da an Health Investment Ltd. (China) II-64
Gamma-Dynacare Medical Laboratories (Canada) II-64
Genoptix Medical Laboratory (US) II-65
Genova Diagnostics, Inc. (US) II-65
Kingmed Diagnostics (China) II-65
Healthscope Ltd. (Australia) II-66
Laboratory Corporation of America Holdings (US) II-66
Labco S.A. (France) II-67
Mayo Medical Laboratories (US) II-67
Myriad Genetic, Inc. (US) II-68
Pathology, Inc. (US) II-68
Prometheus Laboratories, Inc. (US) II-68
Quest Diagnostics, Inc. (US) II-69
Sonic Healthcare Limited (Australia) II-69
American Esoteric Laboratories (US) II-69
Spectra Laboratories, Inc. (US) II-70
Thyrocare Technologies Limited (India) II-70
The National Health Laboratory Service (South Africa) II-70
Unilabs SA (Switzerland) II-71

7. GLOBAL MARKET PERSPECTIVE II-72
Table 15: World Recent Past, Current and Future Analysis for
Clinical Laboratory Services by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2012 through 2020 (includes
corresponding Graph/Chart) II-72

Table 16: World Historic Review for Clinical Laboratory
Services by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2011 (includes corresponding
Graph/Chart) II-73

Table 17: World 15-Year Perspective for Clinical Laboratory
Services by Geographic Region - Percentage Breakdown of
Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin
America, and Rest of World Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) II-74

Table 18: World Recent Past, Current and Future Analysis for
Hospital-based Medical Laboratories by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2012 through 2020 (includes
corresponding Graph/Chart) II-75

Table 19: World Historic Review for Hospital-based Medical
Laboratories by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2011 (includes corresponding
Graph/Chart) II-76

Table 20: World 15-Year Perspective for Hospital-based Medical
Laboratories by Geographic Region - Percentage Breakdown of
Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin
America, and Rest of World Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) II-77

Table 21: World Recent Past, Current and Future Analysis for
Other Laboratories by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) II-78

Table 22: World Historic Review for Other Laboratories by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America, and Rest of World Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for Years
2006 through 2011 (includes corresponding Graph/Chart) II-79

Table 23: World 15-Year Perspective for Other Laboratories by
Geographic Region - Percentage Breakdown of Revenues for US,
Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest
of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-80

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Clinical Laboratories: A Small Yet Vital Constituent of
Healthcare Industry III-1
Table 24: US Healthcare Spending (2012): Percentage Share
Breakdown of Spending by Segment - Hospitals, Professional
Services, Prescriptions, Medical Products, Laboratory
Testing, and Others (includes corresponding Graph/Chart) III-1
Changing Healthcare Industry Dynamics Affect Clinical Lab
Testing Market III-1
Table 25: Healthcare Spending as a % of GDP (includes
corresponding Graph/Chart) III-2
Positive Outlook for Clinical Laboratory Services Market III-3
Current and Future Analysis III-4
A Glance at Major Growth Drivers III-5
Unmet Diagnostic Needs of Aging Population III-5
Table 26: North American Elderly Population by Age Group
(1975-2050) (includes corresponding Graph/Chart) III-6

Table 27: US Population Breakdown by Age Group (2012)
(includes corresponding Graph/Chart) III-7
Increasing Burden of Chronic Diseases Drives Focus onto
Early Detection & Prevention III-7
Cancer Statistics in the US III-7
Table 28: New Cancer Cases by Gender and Affected Site in
the US (2013) III-8
Prevalence of Diabetes Mellitus in North America III-9
Table 29: Prevalence of Diabetes Mellitus in North
America (2012) (includes corresponding Graph/Chart) III-9
Opportunities in Personalized Medicine and Clinical Trial
Services III-9
Increasing Reimbursement Pressures - Opportunities for
Testing Services III-10
Growing Focus on Early Diagnosis III-10
Impact of Scientific Advances & Role of Healthcare IT
Solutions III-10
Need to Reduce Healthcare Costs III-10
Legislative, Regulatory and Policy Environment III-11
Opportunities for Individual Testing III-11
Population Screening Initiatives III-11
Challenges Facing Clinical Labs Market III-11
Product-Related Trends III-13
Table 30: Clinical Laboratory Testing Market in the US
(2010): Percentage Share Breakdown of Revenues by Segment
(includes corresponding Graph/Chart) III-13
Routine Tests: The Largest Product Category III-13
Anatomic Pathology & Cytology Testing: Personalized
Medicine Presents Positive Future III-13
Table 31: US Market for Outpatient Anatomic Pathology
Testing (2010): Percentage Share Breakdown of Revenues by
Test Type - Pap Smears, Skin Biopsies, Gynecology
Biopsies, Prostate, Gastrointestinal, and Others (includes
corresponding Graph/Chart) III-14
Esoteric Testing Market: Faster Growth than Routine Testing
Segment III-14
Molecular Diagnostics: Promising Growth Opportunities III-15
Drugs of Abuse Testing: Prospects Linked to Employment Levels III-16
Future Holds Promise for Specialty Testing Market III-16
Impact of Healthcare Spending Cuts on Routine & Specialty
Lab Tests III-16
Increasing Role of Advanced Tests in Clinical Treatment
Decision Making III-16
Tissue-based Diagnostics Market to Expand III-17
Toxicology Laboratories Market: An Insight III-17
Genetic and Genomic Clinical Lab Testing Market: Promising
Prospects III-17
Shift towards Managed Care - A Challenge for Independent
Clinical Labs? III-19
Evolving ACO Business Model: A Challenge for Independent Labs III-19
Integration of Clinical Care: Impact on Clinical Labs &
Anatomic Pathology Groups III-20
Hospital Laboratory Outreach Programs: On the Rise III-21
Physician Practices: The New Acquisition Targets III-21
Table 32: % of Independent Physicians in the US
(2005-2013) (includes corresponding Graph/Chart) III-22
Cost Cutting Measures to Hit Lab Outreach Testing Business? III-22
Hospitals Foray into Health Insurance Market: Opportunities
for Hospital Labs III-22
FDA to Regulate Laboratory Developed Tests (LDTs) III-23
Shortened Hospital Stay Enhances Significance of Medical Labs III-23
Lab Automation: A Key Trend in the Clinical Laboratory
Testing Market III-23
Health Plans Interpose Between Clinical Labs and Physicians III-24
POCT Segment Withstands Cost Pressures III-24
Dealing with Regulatory Changes: A Tough Ask for Clinical Labs III-24
CMS Proposes to Slash Payment for Lab Tests III-25
Providers of Clinical Laboratory Service in the US: A Review III-25
Hospital-Based Labs III-25
Table 33: Hospital Lab Test Market in the US (2012):
Percentage Share Breakdown of Revenues by Payer (includes
corresponding Graph/Chart) III-26

Table 34: Registered Hospitals in the US (2012):
Percentage Share Breakdown of Number of Hospitals by Type
of Hospital (includes corresponding Graph/Chart) III-27
Independent Labs III-27
Table 35: Independent Labs Market in the US (2012):
Percentage Share Breakdown of Revenues for Quest
Diagnostics, LabCorp, Small Independent Labs, Niche Labs,
and Tier 2 Labs (includes corresponding Graph/Chart) III-28
Physician Office-Based Labs and Others III-28
Competitive Landscape III-29
Consolidation Activity Gathers Pace in Clinical Laboratory
Testing Market III-30
Table 36: Number of Closed M&A Transactions in the US
Clinical Labs Market (2005-2012) (includes corresponding
Graph/Chart) III-31

Table 37: Closed M&A Transactions in the US Clinical Labs
Market (2009-2012): Breakdown by Clinical Labs and
Anatomic Pathology & Specialty Labs (includes
corresponding Graph/Chart) III-31
Major Clinical Laboratory Transactions (2011-2013) III-32
Regulatory Landscape III-34
A2LA III-34
ASCLS III-34
CAP III-34
Clinical Laboratory Improvement Amendments (CLIA) III-35
Table 38: CLIA-Certified Laboratories in the US (2013):
Percentage Share Breakdown of Number of Laboratories by
Certificate Type (includes corresponding Graph/Chart) III-36

Table 39: CLIA-Certified Laboratories in the US (2013):
Percentage Share Breakdown of Number of Labs by Lab Type
(includes corresponding Graph/Chart) III-36
Health Insurance Portability and Accountability Act of 1996 III-37
Substance Abuse and Mental Health Services Administration
(SAMHSA) Regulation III-37
Reimbursement Scenario for Clinical Laboratory Tests III-37
Impact on Funding Changes on Clinical Labs Testing Market III-38
Medicare Coverage for Screening Tests III-38
Medicare Clinical Laboratory Fee Schedule (CLFS) III-39
Medicare Physician Fee Schedule (MPFS) III-39
Medicaid III-40
Payment and Coding for Clinical Laboratory Testing Services III-40
Table 40: Medicare Spending in the US (2012): Percentage
Share Breakdown of Spending by Category - Inpatient
Hospital, Managed Care, Prescription Drugs, Physician Fee
Schedule, SNF, Home Health, Hospice, Clinical Laboratory,
and Others (includes corresponding Graph/Chart) III-41
Product Innovations/Introductions III-42
Strategic Corporate Developments III-48
Key Players III-64
B.Market Analytics III-71
Table 41: US Recent Past, Current and Future Analysis for
Clinical Laboratory Services by Location - Hospital-Based
Laboratories, Independent Laboratories, and Physician Office
Laboratories Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2012 through 2020
(includes corresponding Graph/Chart) III-71

Table 42: US Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories,
Independent Laboratories, and Physician Office Laboratories
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2006 through 2011 (includes
corresponding Graph/Chart) III-72

Table 43: US 15-Year Perspective for Clinical Laboratory
Services by Location - Percentage Breakdown of Revenues for
Hospital-Based Laboratories, Independent Laboratories, and
Physician Office Laboratories Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) III-73

2. CANADA III-74
A.Market Analysis III-74
Outlook III-74
Rising Incidence of Chronic Diseases Spurs Need for Testing III-74
Table 44: New Cancer Cases in Canada by Gender and Affected
Site (2012) (includes corresponding Graph/Chart) III-75

Table 45: New Cancer Cases in Canada by Province (2012)
(includes corresponding Graph/Chart) III-76

Table 46: New Cancer Cases in Canada by Age Group and
Gender (2012) (includes corresponding Graph/Chart) III-77

Table 47: Prevalence of Diabetes Mellitus in Canada (2012)
(includes corresponding Graph/Chart) III-78
Funding Crunch Bolsters Consolidation Activity among
Independent Labs III-78
Regulatory Scenario in Canada III-78
Accreditation Canada III-78
Standards Council of Canada III-80
Strategic Corporate Developments III-82
Gamma-Dynacare Medical Laboratories - A Key Player III-85
B.Market Analytics III-86
Table 48: Canadian Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-86

Table 49: Canadian Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-87

Table 50: Canadian 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-88

3. JAPAN III-89
A.Market Analysis III-89
Outlook III-89
Demographics Drive Market Growth III-89
Table 51: Percentage Breakdown of Japanese Population by
Age Group (2012) (includes corresponding Graph/Chart) III-89
Table 52: Over 65 Years Population in Japan (1950-2010)
(includes corresponding Graph/Chart) III-90

Table 53: Prevalence of Diabetes Mellitus in Japan (2012 &
2030) (includes corresponding Graph/Chart) III-90
Strategic Corporate Development III-91
B.Market Analytics III-92
Table 54: Japanese Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-92

Table 55: Japanese Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-93

Table 56: Japanese 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-94

4. EUROPE III-95
A.Market Analysis III-95
Outlook III-95
Overview III-95
Table 57: Diagnostics Market in Europe (2012): Percentage
Share Breakdown of Revenues by Medical Imaging, Laboratory
Testing, and Anatomic Pathology (includes corresponding
Graph/Chart) III-95
Debt Crisis in Europe Affects Healthcare Industry III-96
European Healthcare System: In a State of Transition? III-96
Aging Population to Drive Demand for Medical Laboratory
Services III-97
Table 58: Population Breakup by Age Group for Select
European Countries: 2012 (As a % of Total Population)
(includes corresponding Graph/Chart) III-98
Accreditation and Regulatory Scenario in the EU III-99
B.Market Analytics III-100
Table 59: European Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Geographic Region -
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2012 through 2020 (includes
corresponding Graph/Chart) III-100

Table 60: European Historic Review for Clinical Laboratory
Services by Geographic Region - France, Germany, Italy, UK,
Spain, Russia, and Rest of Europe Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2006 through 2011 (includes corresponding Graph/Chart) III-101

Table 61: European 15-Year Perspective for Clinical
Laboratory Services by Geographic Region - Percentage
Breakdown of Revenues for France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) III-102

Table 62: European Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-103

Table 63: European Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-104

Table 64: European 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-105

4a. FRANCE III-106
A.Market Analysis III-106
Outlook III-106
Overview III-106
Table 65: 65+ Population as % of Total Population (includes
corresponding Graph/Chart) III-106

Table 66: Clinical Testing Laboratories in France (2012):
Percentage Share Breakdown of Number of Labs by Type
(includes corresponding Graph/Chart) III-107
Labco S.A. - A Key Player III-107
B.Market Analytics III-108
Table 67: French Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-108

Table 68: French Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-109

Table 69: French 15-Year Perspective for Clinical Laboratory
Services by Location - Percentage Breakdown of Revenues for
Hospital-Based Laboratories, and Other Laboratories Markets
for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-110

4b. GERMANY III-111
A.Market Analysis III-111
Outlook III-111
Privatization: A Visible Trend in the Labs Market III-111
Regulatory Scenario in Germany III-111
DAkkS GmbH - Germany's National Accreditation Body III-111
Bioscientia Institut für Medizinische Diagnostik GmbH - A
Key Player III-112
B.Market Analytics III-112
Table 70: German Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-112

Table 71: German Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-113

Table 72: German 15-Year Perspective for Clinical Laboratory
Services by Location - Percentage Breakdown of Revenues for
Hospital-Based Laboratories, and Other Laboratories Markets
for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-114

4c. ITALY III-115
A.Market Analysis III-115
Outlook III-115
ACCREDIA - The Italian Accreditation Body III-115
B.Market Analytics III-116
Table 73: Italian Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-116

Table 74: Italian Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-117

Table 75: Italian 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-118

4d. THE UNITED KINGDOM III-119
A.Market Analysis III-119
Outlook III-119
UKAS - The Sole National Accreditation Body in the UK III-119
B.Market Analytics III-120
Table 76: UK Recent Past, Current and Future Analysis for
Clinical Laboratory Services by Location - Hospital-Based
Laboratories, and Other Laboratories Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2012 through 2020 (includes corresponding Graph/Chart) III-120

Table 77: UK Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-121

Table 78: UK 15-Year Perspective for Clinical Laboratory
Services by Location - Percentage Breakdown of Revenues for
Hospital-Based Laboratories, and Other Laboratories Markets
for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-122

4e. SPAIN III-123
A.Market Analysis III-123
Outlook III-123
Strategic Corporate Development III-123
B.Market Analytics III-124
Table 79: Spanish Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-124

Table 80: Spanish Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-125

Table 81: Spanish 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-126

4f. RUSSIA III-127
Market Analysis III-127
Table 82: Russian Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-127

Table 83: Russian Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-128

Table 84: Russian 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-129

4g. REST OF EUROPE III-130
A.Market Analysis III-130
Outlook III-130
Poland III-130
Switzerland III-130
Ukraine III-130
Strategic Corporate Developments III-131
Unilabs SA (Switzerland) - A Key Player III-131
B.Market Analytics III-132
Table 85: Rest of Europe Recent Past, Current and Future
Analysis for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-132

Table 86: Rest of Europe Historic Review for Clinical
Laboratory Services by Location - Hospital-Based
Laboratories, and Other Laboratories Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2006 through 2011 (includes corresponding Graph/Chart) III-133

Table 87: Rest of Europe 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-134

5. ASIA-PACIFIC III-135
A.Market Analysis III-135
Overview III-135
Healthcare Spending in Asia-Pacific: On the Rise III-135
China and India: Two Fast-Growing Markets III-136
APLAC - A Regional Accreditation Body in Asia-Pacific III-136
B.Market Analytics III-137
Table 88: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Laboratory Services by Geographic
Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-137

Table 89: Asia-Pacific Historic Review for Clinical
Laboratory Services by Geographic Region - China and Rest of
Asia-Pacific Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2006 through 2011
(includes corresponding Graph/Chart) III-138

Table 90: Asia-Pacific 15-Year Perspective for Clinical
Laboratory Services by Geographic Region - Percentage
Breakdown of Revenues for China and Rest of Asia-Pacific
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-139

Table 91: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-140

Table 92: Asia-Pacific Historic Review for Clinical
Laboratory Services by Location - Hospital-Based
Laboratories, and Other Laboratories Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2006 through 2011 (includes corresponding Graph/Chart) III-141

Table 93: Asia-Pacific 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-142

5a. CHINA III-143
A.Market Analysis III-143
Outlook III-143
Medical Labs Market: An Overview III-143
Healthcare Reforms: Opportunities for Clinical Labs Market III-143
Independent Clinical Labs - A Nascent Market III-144
Table 94: Leading Independent Medical Labs in China (2013):
Percentage Share Breakdown of Revenues for KingMed
Diagnostics, DiAn Diagnostics, Adicon Clinical Laboratories
Inc., DaAn Health, and Others (includes corresponding
Graph/Chart) III-145
CNAL - The National Accreditation Body in China III-146
HKAS - An Accreditation Body in Hong Kong III-146
Strategic Corporate Developments III-147
Key Players III-149
B.Market Analytics III-151
Table 95: Chinese Recent Past, Current and Future Analysis
for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2012 through 2020 (includes corresponding
Graph/Chart) III-151

Table 96: Chinese Historic Review for Clinical Laboratory
Services by Location - Hospital-Based Laboratories, and
Other Laboratories Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2006 through
2011 (includes corresponding Graph/Chart) III-152

Table 97: Chinese 15-Year Perspective for Clinical
Laboratory Services by Location - Percentage Breakdown of
Revenues for Hospital-Based Laboratories, and Other
Laboratories Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-153

5b. REST OF ASIA-PACIFIC III-154
A.Market Analysis III-154
Outlook III-154
Review of Select Regional Markets III-154
Australia III-154
Strong Growth in Lab Testing Leads to Increased Private
Health Insurance Premiums III-154
NATA - An Australian Regulatory Agency III-154
India III-155
Clinical Laboratory Market: Overview III-155
Growth Drivers III-156
Challenges III-156
Table 98: Indian Medical Laboratories Market (2010):
Percentage Share Breakdown of Revenues by Type of Lab -
High-End Labs, Regional Labs, and Manual Labs (includes
corresponding Graph/Chart) III-157

Table 99: Indian Clinical Laboratory Market (2013E):
Percentage Share Breakdown of Revenues by Segment -
Biochemistry, Immunology, Hematology, Microbiology,
Histopathology, Molecular, and Genetics (includes
corresponding Graph/Chart) III-158
Biochemistry Analysis: An Important Clinical Lab Segment III-158
Competitive Landscape III-158
Business Model of Medical Labs III-159
Table 100: Indian Medical Laboratories Market (2013)):
Number of Labs and Collection Centers Operated by
Metropolis, SRL Diagnostics, and Dr. Lal Path Labs III-160
Regulatory Scenario in India III-160
Indonesia III-160
Korea III-160
Rapidly Aging Population Spurs Demand for Clinical Lab
Testing III-160
Table 101: South Korean Medical Laboratories Market
(2010): Percentage Share Breakdown of Medical
Laboratories by Healthcare Segment - Immunochemistry,
Infectious Disease, Clinical Chemistry, Microbiology,
Hematology, Molecular Biology, and Others (includes
corresponding Graph/Chart) III-161
KOLAS - The National Accreditation Agency of Korea III-161
Philippines III-162
Regulatory Scenario in Philippines III-162
Singapore III-162
SAC - The National Agency for Accreditation in Singapore III-162
Thailand III-162
BLQS - A Designated Accreditation Authority in Thailand III-162
Strategic Corporate Developments III-163
Key Players III-164
B.Market Analytics III-165
Table 102: Rest of Asia-Pacific Recent Past, Current and
Future Analysis for Clinical Laboratory Services by Location -
Hospital-Based Laboratories, and Other Laboratories
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2012 through 2020 (includes
corresponding Graph/Chart) III-165

Table 103: Rest of Asia-Pacific Historic Rev

Read the full report:
Global Clinical Laboratory Services Industry

http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_clinical_laboratory_services_industry.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS
http://www.reportbuyer.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.